Endoscopic Retrograde Cholangiopancreatography(ERCP)-Related Discussion Through a Mobile Social App by a Group of Doctors

January 9, 2016 updated by: Yanglin Pan, Air Force Military Medical University, China

Endoscopic Retrograde Cholangiopancreatography(ERCP)-Related Discussion Through a Mobile Social App by Trainees After Finishing ERCP Training

Group chat through the platform of mobile social networking provides an easily accessible, real-time and interactive channel for communication. With the help of mobile social app, a group of doctors with similar interests can share valuable cases, important papers and opinions through multiple media types (texts, images, and videos). It remains unknown what activities of Endoscopic Retrograde Cholangiopancreatography(ERCP) doctors on a group-chat platform are.

In the beginning of 2013, a chatting group on Wechat (the most popular mobile social app in China), focusing on ERCP, was created. All the doctors who received and finished their ERCP training in Xijing Hospital of Digestive Diseases were invited to join in the platform. The contents in the chatting group were analyzed. The relationships between the chatting activities of ERCP doctors and the performance of ERCP (such as case volume, cannulation success rate and PEP etc.) were investigated.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Anticipated)

60

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • China
    • Shaanxi
      • Xi'an, Shaanxi, China
        • Xijing Hospital of Digestive Diseases

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Doctors who received and finished their ERCP training in Xijing Hospital of Digestive Diseases and joined in a chatting group through a mobile social app

Description

Inclusion Criteria:

  • Doctors who received and finished their ERCP training in Xijing Hospital of Digestive Diseases and joined in a chatting group in a mobile social app (Wechat).

Exclusion Criteria:

  • Unable to join in the chatting group
  • Unable to finish the questionaire
  • Denying participating in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
ERCP-chat group
All the doctors who finished their ERCP training in Xijing Hospital of Digestive Diseases and were invited to join in a chatting group in a mobile social app (Wechat).
Other: joining in the platform
The activities (contents, chatting frequency etc.) of ERCP doctors on the chatting group were retrospectively extracted. The data related to the performance of ERCP (such as case volume, cannulation success rate and PEP etc.) by ERCP doctors were collected by a questionaire.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Chatting frequency
Time Frame: 1 year
1 year

Secondary Outcome Measures

Outcome Measure
Time Frame
Difficulty grade of the discussed case
Time Frame: 1 year
1 year
Number of biliary duct-related cases
Time Frame: 1 year
1 year
ERCP performance volumes
Time Frame: 1 year
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Air Force Military Medical University, China

Investigators

  • Principal Investigator: Yanglin Pan, Xijing Hospital of Disgestive Diseases.The Fourth Military University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2015

Primary Completion (Actual)

January 1, 2016

Study Completion (Actual)

January 1, 2016

Study Registration Dates

First Submitted

August 13, 2015

First Submitted That Met QC Criteria

August 31, 2015

First Posted (Estimate)

September 1, 2015

Study Record Updates

Last Update Posted (Estimate)

January 12, 2016

Last Update Submitted That Met QC Criteria

January 9, 2016

Last Verified

January 1, 2016

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 20150611-4

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on joining in the platform

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mongolia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe